About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Expression of PARP-1 in Multiple Sclerosis Patients

Expression of PARP-1 in Multiple Sclerosis Patients

NCT05196425·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Sohag University

Age

20–45

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Patients with multiple sclerosis with or without optic neuritis Multiple sclerosis will be diagnosed according to the McDonald criteria

You may not be if

• Isolated optic neuritis.

The record

StatusCompleted

PhaseNo phase

Taking part80

StartedAug 2021

UpdatedMay 2, 2025

Conditions

Multiple Sclerosis

Where1

Elshimaa A.Mateen
Sohag, Egypt